14
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2007
Study Completion Date
October 31, 2007
Xolair
Xolair 150-375 mg SQ every 2 or 4 weeks based on body weight and pre treatment IgE level.
Xolair
Xolair 150-375 mg SQ every 2 or 4 weeks based on body weight and pre treatment IgE level.
University of Mississippi Medical Center, Jackson
Collaborators (1)
Novartis
INDUSTRY
University of Mississippi Medical Center
OTHER